NCT02861612

Brief Summary

This study seeks to evaluate the efficacy of nerve transfers in restoring hand function in patients with cervical spinal injuries.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2016

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2016

Completed
19 days until next milestone

Study Start

First participant enrolled

August 1, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 10, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2019

Completed
Last Updated

March 21, 2019

Status Verified

March 1, 2019

Enrollment Period

2.6 years

First QC Date

July 13, 2016

Last Update Submit

March 19, 2019

Conditions

Keywords

peripheral nervesquadriplegianerve transfersurgical procedures, operativehandupper extremityquality of life

Outcome Measures

Primary Outcomes (4)

  • Upper extremity function - Myometric measures of strength (donor and recipient muscle groups)

    Valid and reliable quantitative muscle strength measurement

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Upper extremity function - Manual muscle testing (MRC)

    Quantitative assessment of motor function (MRC)

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Upper extremity function - Graded Redefined Assessment of Strength, Sensibility and Prehension test (GRASSP)

    Valid, reliable and responsive measure of sensorimotor upper limb impairment specifically designed for patients with cervical SCI

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Upper extremity function - Range of motion

    Quantitative assessment of range of motion (degrees)

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

Secondary Outcomes (4)

  • Health related quality of life - The Short Form (SF)-36

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Health related quality of life - Spinal Cord Independence Measure (SCIM I)

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Health related quality of life - Canadian Occupational Performance Measure (COPM)

    Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

  • Health related quality of life - Semi-structured interviews

    Collected at 12 and 24 months post-surgery.

Study Arms (1)

Nerve Transfer

This is an observational study that looks at function and quality of life in patients before and after nerve transfer surgery.

Procedure: Nerve Transfer Surgery

Interventions

Unilateral surgery will be performed under general non-paralytic anesthesia and no-tourniquet conditions to allow for responsive nerve simulation.

Nerve Transfer

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Any patients with cervical spinal cord injury and upper extremity dysfunction who are medically stable, residents of Canada, willing and able to be assessed at the The Ottawa Hospital are potential participants.

You may qualify if:

  • Patients with a spinal cord injury AIS level C5 to C7. Those with motor complete injuries (AIS A or B) will be considered for surgical intervention if they are ≥ 5 months post injury. Motor incomplete patients (AIS C or D) will be considered if they are ≥ 1.5 years post injury.
  • Patients will require ≥ MRC 4 strength of the muscle supplied by the donor nerve (e.g. brachialis, supinator).
  • Finger flexor and extensor strength should be ≤ MRC 1 strength.
  • Muscles supplied by the donor nerve, will need to have no or minimal of evidence of lower motor neuron injury as dictated by evidence of fibrillations, positive sharp waves, or moderate or severely decreased recruitment on needle electromyography.
  • Those being evaluated for surgery outside nine-months post injury recipient muscles will be required to be free of lower motor neuron pathology.
  • Ability to comply and participate in rigorous post-surgical therapy regimen.

You may not qualify if:

  • Comorbidities precluding safe surgery including autonomic/hemodynamic instability, pulmonary instability, active infection, chronic pressure sores or untreated urinary tract infections as determined by physician.
  • Simultaneous tendon transfer or tenodesis surgery (which would preclude separation of the effect of nerve transfer alone).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

The Ottawa Hospital

Ottawa, Ontario, K1Y 4E9, Canada

Location

Related Publications (2)

  • Fox IK, Davidge KM, Novak CB, Hoben G, Kahn LC, Juknis N, Ruvinskaya R, Mackinnon SE. Nerve Transfers to Restore Upper Extremity Function in Cervical Spinal Cord Injury: Update and Preliminary Outcomes. Plast Reconstr Surg. 2015 Oct;136(4):780-792. doi: 10.1097/PRS.0000000000001641.

    PMID: 26397252BACKGROUND
  • Fox IK, Davidge KM, Novak CB, Hoben G, Kahn LC, Juknis N, Ruvinskaya R, Mackinnon SE. Use of peripheral nerve transfers in tetraplegia: evaluation of feasibility and morbidity. Hand (N Y). 2015 Mar;10(1):60-7. doi: 10.1007/s11552-014-9677-z.

    PMID: 25767422BACKGROUND

MeSH Terms

Conditions

QuadriplegiaSpinal Cord DiseasesSpinal Cord Injuries

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCentral Nervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Kirsty U Boyd, MD

    The Ottawa Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2016

First Posted

August 10, 2016

Study Start

August 1, 2016

Primary Completion

March 18, 2019

Study Completion

March 18, 2019

Last Updated

March 21, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations